Among the key findings was the overexpression of NOTCH4, a Notch receptor known to promote stemness, invasiveness, and treatment resistance, particularly in aggressive breast cancer subtypes [22,23,24]. The gene discussed is NOTCH4; the disease is breast carcinoma.